A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19
一项针对轻度至中度 COVID-19 患者的纤溶酶原激活物抑制剂-1 (TM5614) 的随机双盲安慰剂对照试验
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-50445-1
Hirai, Toyohiro; Asano, Koichiro; Ito, Isao; Miyazaki, Yasunari; Sugiura, Hisatoshi; Agirbasli, Mehmet; Kobayashi, Seiichi; Kobayashi, Makoto; Shimada, Daishi; Natsume, Ichiro; Kawasaki, Tsutomu; Ohba, Takehiko; Tajiri, Sakurako; Sakamaki, Fumio; Mineshita, Masamichi; Takihara, Takahisa; Sekiya, Kiyoshi; Tomii, Keisuke; Tomioka, Hiromi; Kita, Hideo; Nishizaka, Yasuo; Fukui, Motonari; Miyata, Toshio; Harigae, Hideo